MediWound Ltd. (MDWD): Growth-Adjusted P/E Ratio

Symbol and logo of brand MediWound, Ltd. (MDWD)

High technological barriers and enzyme patents have secured MediWound Ltd. (MDWD) an elite status among surgeons. The average peg_co level illustrates this market position, where the 0.00 metric captures the current valuation. The specifics of burn treatment make the business crisis-resistant, as demand for emergency care remains independent of economic cycles.

MDWD - MediWound Ltd Price/Earnings to Growth Ratio over the range 07/04/2022 - 11/12/2026

Analytical breakdowns for MediWound Ltd. (MDWD)

- current quotes and average value forecast:
Market Price mediwound.com|MDWD - Price Target Chart
- stock exchange capitalization data:
Market Capitalization MediWound, Ltd.|MDWD - Real Price to Acquire Entire Company
- business book valuation details:
Book Price of a Share MediWound Ltd.|MDWD - Company Book Value|Market Cap to Net Assets Ratio mediwound.com|MDWD - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital MediWound Ltd.|MDWD - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio mediwound.com|MDWD - Company Aggregate Debts|Debts to Net Assets MediWound, Ltd.|MDWD - Company Long-Term Liabilities|Company Current Liabilities MediWound Ltd.|Immediate Liquidity mediwound.com
- earnings and market ratios statistics:
MDWD - Net Income|Projected Future Earnings MediWound Ltd.|MDWD - Price to Earnings Ratio|Price to Future Earnings Ratio mediwound.com|MDWD - PEG Multiple|Enterprise Value to Operating Income Before Depreciation MediWound, Ltd.|MDWD - Operating profit before deduction of amortization|Earnings per share for the trailing year MediWound Ltd.|MDWD - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months mediwound.com|MDWD - Net earnings per share growth this year|Projected earnings per share increase next year MediWound Ltd.
General company analysis:MDWD, MediWound Ltd
Mass-produced product of MediWound Ltd

Professional selection of undervalued assets is based on identifying securities where earnings growth outpaces market value. By analyzing the PEG ratio, which correlates the P/E multiple with projected earnings growth, an investor reveals the hidden potential of MediWound Ltd. (MDWD), supported by the commercialization of NexoBrid, US government contracts, and the development of EscharEx therapy for the treatment of chronic wounds.

Who MediWound Ltd. competes with

HCA - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Tenet THC|FMS: Growth-Adjusted P/E Ratio|SOLV: Price/Earnings to Growth Multiple|encompasshealth.com - Company Value to Earnings Growth Ratio|uhsinc.com (UHS) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple DaVita HealthCare Partners|RDNT (RadNet Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Option Care Corp OPCH|PEG Multiple SGRY|premierinc.com - Growth-Adjusted P/E Ratio|PEG Multiple EYE (National Vision)|Growth-Adjusted Market Cap to Net Income Progyny Inc (PGNY)|ARDT: Price/Earnings to Growth Multiple|Select Medical Inc. (SEM) - Price/Earnings to Growth Multiple|Astrana Health, Inc. (ASTH) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate Pediatrix Medical Group (MD)|Price/Earnings to Growth Multiple USPH|PEG Multiple Pennant Group|Price/Earnings to Growth Ratio Organogenesis Inc. (ORGO)|Nutex Health Hospitals - Growth-Adjusted P/E Ratio|PEG Multiple AUNA (Auna SA)|SBC: Growth-Adjusted P/E Ratio|EOLS: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio CYH (CHS)|beautyhealth.com (SKIN) - Price/Earnings to Growth Ratio|BTMD (Biote Corporation) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple JYNT|DCGO (docgo.com) - Company Value to Earnings Growth Ratio|PEG Multiple PIII|Gain Therapeutics Inc. - Growth-Adjusted P/E Ratio|EUDA Health - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income Basel Medical (BMGL)|CLGN - Price/Earnings to Growth Ratio|cuprina.com.sg (CUPR) - Price/Earnings to Growth Multiple|CCM: PEG Multiple|Growth-Adjusted P/E Ratio AMS|Price/Earnings to Growth Multiple MRM|Price/Earnings to Growth Multiple Avalon GloboCare Corporation (ALBT)|PEG Multiple DHAI|carmellcosmetics.com - Growth-Adjusted P/E Ratio|NewGenIvf - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio ATIP (ATI Physical Therapy Inc.)|CMAX - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio KDLY (Kindly Health)|MODV: PEG Multiple|Price to Earnings Adjusted for Growth Rate novointegrated.com (NVOS)|SSY (SunLink Health Systems Inc.) - PEG Multiple|PEG Multiple IMAC Holdings Inc